Literature DB >> 6463670

Differences among practitioners in patterns of preference for information sources in the adoption of new drugs.

M Y Peay, E R Peay.   

Abstract

The major aim of this study was to identify coherent patterns in doctors' preferences for potential sources of information about new drugs and the characteristics of the doctors who display them. One hundred twenty-four general practitioners and specialists evaluated and reported their use of a number of potential sources. Overall, commercial sources were cited more often than professional ones for providing first information about a new drug, but the reverse was the case when the doctor was actively considering prescribing it. The primary professional sources received more favourable evaluation than any of the commercial sources, but results suggest that usage does not necessarily follow the doctor's opinion of a source. Relationships between reported use and evaluation reveal two coherent patterns of source preference: 'journal' and 'commercial'. The commercial pattern is particularly sharply defined, identifying a subset of doctors who can be designated justifiably as 'commercially-oriented'. Evaluation and use of particular sources varied with age and differed between specialists and general practitioners. Results indicate that differences in patterns of preference are systematically related to characteristics of the doctor in combination with the stage of the adoption process.

Mesh:

Year:  1984        PMID: 6463670     DOI: 10.1016/0277-9536(84)90160-6

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  15 in total

1.  Access and use of medicines information sources by physicians in public hospitals in Uganda: a cross-sectional survey.

Authors:  Winifred A Tumwikirize; Jasper W Ogwal-Okeng; Osa Vernby; Willy W Anokbonggo; Lars L Gustafsson; Cecilia S Lundborg
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

Review 2.  Therapeutic decision making of physicians.

Authors:  P Denig; F M Haaijer-Ruskamp
Journal:  Pharm Weekbl Sci       Date:  1992-02-21

3.  Health professionals: how do they assess new medicines?

Authors:  Rebecca Cheng; Kirsty Cook; Sarah Dowman; Rebecca Lawn; Jemma Leary; Taryn Quinn; Kim Schroder; Nicola Smith; June Tordoff
Journal:  Pharm World Sci       Date:  2005-06

4.  Drug use in pregnancy--physicians' evaluation of quality and clinical impact of drug information centres.

Authors:  Sofia Kristina Frost Widnes; Jan Schjøtt
Journal:  Eur J Clin Pharmacol       Date:  2008-12-04       Impact factor: 2.953

5.  Identification and physicians' views of their commonly-used drug information sources in Singapore.

Authors:  Hui-Ling Lua; Grant Sklar; Yu Ko
Journal:  Int J Clin Pharm       Date:  2011-07-08

6.  Introducing a new drug into your practice.

Authors:  W H Palmer; D L Ross
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

7.  The determinants of physician attitudes and subjective norms toward drug information sources: modification and test of the theory of reasoned action.

Authors:  C A Gaither; R P Bagozzi; F J Ascione; D M Kirking
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

8.  A reasoned action approach to physicians' utilization of drug information sources.

Authors:  C A Gaither; R P Bagozzi; F J Ascione; D M Kirking
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

Review 9.  Interactions between physicians and the pharmaceutical industry: what does the literature say?

Authors:  J Lexchin
Journal:  CMAJ       Date:  1993-11-15       Impact factor: 8.262

10.  Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.

Authors:  C Watkins; I Harvey; P Carthy; L Moore; E Robinson; R Brawn
Journal:  Qual Saf Health Care       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.